InsiderSource

Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS · SEC CIK 2010019
Insider at NTRA Natera, Inc.
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$25.18M
92 trades
Net flow
−$25.18M
Net selling
Total filings
110
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Feb 4, 2026

Moshkevich Solomon sold $3.7K of NTRA.

−$3.7K
16 sh @ $234
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 29, 2026 ΔOwn −0.8%

Moshkevich Solomon sold $285.2K of NTRA, trimming their stake 1%.

−$285.2K
1,200 sh @ $238
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 29, 2026 ΔOwn −0.7%

Moshkevich Solomon sold $243.7K of NTRA, trimming their stake 1%.

−$243.7K
1,013 sh @ $241
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 22, 2026 ΔOwn −0.2%

Moshkevich Solomon sold $68.9K of NTRA.

−$68.9K
293 sh @ $235
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 22, 2026 ΔOwn −14%

Moshkevich Solomon sold $5.45M of NTRA, trimming their stake 14%.

−$5.45M
23,205 sh @ $235
Advertisement
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 6, 2026 ΔOwn −1.0%

Moshkevich Solomon sold $295K of NTRA, trimming their stake 1%.

−$295K
1,292 sh @ $228
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Jan 6, 2026 ΔOwn −1.3%

Moshkevich Solomon sold $380.6K of NTRA, trimming their stake 1%.

−$380.6K
1,659 sh @ $229
NTRA
Natera, Inc.
Option exercise Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Option exercise · filed Dec 16, 2025 ΔOwn +8.2%
+$85.1K
8,876 sh @ $10
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Dec 16, 2025 ΔOwn −4.0%

Moshkevich Solomon sold $1.08M of NTRA, trimming their stake 4%.

−$1.08M
4,692 sh @ $231
NTRA
Natera, Inc.
Option exercise Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Option exercise · filed Dec 16, 2025 ΔOwn +12%
+$129.5K
13,500 sh @ $10
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Dec 3, 2025 ΔOwn −0.7%

Moshkevich Solomon sold $177.7K of NTRA, trimming their stake 1%.

−$177.7K
749 sh @ $237
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Dec 3, 2025 ΔOwn −0.2%

Moshkevich Solomon sold $59.4K of NTRA.

−$59.4K
250 sh @ $238
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Dec 3, 2025 ΔOwn −1.4%

Moshkevich Solomon sold $363.8K of NTRA, trimming their stake 1%.

−$363.8K
1,527 sh @ $238
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Dec 3, 2025 ΔOwn −0.4%

Moshkevich Solomon sold $113.5K of NTRA.

−$113.5K
474 sh @ $240
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −1.3%

Moshkevich Solomon sold $287.1K of NTRA, trimming their stake 1%.

−$287.1K
1,450 sh @ $198
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −1.3%

Moshkevich Solomon sold $288.7K of NTRA, trimming their stake 1%.

−$288.7K
1,450 sh @ $199
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −0.1%

Moshkevich Solomon sold $20K of NTRA.

−$20K
100 sh @ $200
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 29, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $229.4K of NTRA, trimming their stake 1%.

−$229.4K
1,198 sh @ $191
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 29, 2025 ΔOwn −0.9%

Moshkevich Solomon sold $193.9K of NTRA, trimming their stake 1%.

−$193.9K
1,008 sh @ $192
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 22, 2025 ΔOwn −0.2%

Moshkevich Solomon sold $54.9K of NTRA.

−$54.9K
292 sh @ $188
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −0.3%

Moshkevich Solomon sold $64.2K of NTRA.

−$64.2K
404 sh @ $159
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −1.5%

Moshkevich Solomon sold $290.4K of NTRA, trimming their stake 2%.

−$290.4K
1,816 sh @ $160
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −0.7%

Moshkevich Solomon sold $125.3K of NTRA, trimming their stake 1%.

−$125.3K
780 sh @ $161
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $213.7K of NTRA, trimming their stake 1%.

−$213.7K
1,290 sh @ $166
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −0.4%

Moshkevich Solomon sold $83.2K of NTRA.

−$83.2K
500 sh @ $166
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $202.9K of NTRA, trimming their stake 1%.

−$202.9K
1,210 sh @ $168

Frequently asked questions

How is Moshkevich Solomon's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Moshkevich Solomon's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.